ANAB – anaptysbio, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

ANAB

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

4/24

07:32 am

anab

First Tracks Biotherapeutics initiated with an Outperform at Leerink

Low Report

First Tracks Biotherapeutics initiated with an Outperform at Leerink

Report

4/22

09:11 am

anab

Rating for ANAB

Low Report

Rating for ANAB

Report

4/22

09:11 am

anab

Rating for ANAB

Low Report

Rating for ANAB

Report

4/21

03:35 pm

anab

Rating for ANAB

Low Report

Rating for ANAB

Report

3/30

09:02 am

anab

AnaptysBio (ANAB) had its "buy" rating reaffirmed by HC Wainwright. They now have a $66.00 price target on the stock.

Medium Report

AnaptysBio (ANAB) had its "buy" rating reaffirmed by HC Wainwright. They now have a $66.00 price target on the stock.

Report

3/17

12:02 pm

anab

Rating for ANAB

Low Report

Rating for ANAB

Report

3/12

11:18 am

anab

Rating for ANAB

Medium Report

Rating for ANAB

Report

3/12

11:18 am

anab

Rating for ANAB

Medium Report

Rating for ANAB

Report

3/5

07:02 am

anab

Rating for ANAB

Low Report

Rating for ANAB

Report

3/4

09:34 am

anab

Rating for ANAB

Medium Report

Rating for ANAB

Report

3/4

09:34 am

anab

Rating for ANAB

Medium Report

Rating for ANAB

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.